Trial Profile
Voriconazole and Caspofungin Combination Therapy for Invasive Pulmonary Fungal Infection in Paediatric patients with Acute Leukaemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2015
Price :
$35
*
At a glance
- Drugs Caspofungin (Primary) ; Voriconazole (Primary)
- Indications Immunocompromised infections; Mycoses
- Focus Therapeutic Use
- 04 Aug 2015 New trial record
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.